biomarinpharmaceuticalinc notestoconsolidatedfinancialstatements in thousands of u s dollars except per share amounts or as otherwise disclosed thecompany slevel 2 securities are valued using third party pricing sources which generally use ...
Filetype PDF | Posted on 17 Jan 2023 | 4 years ago
The words contained in this file might help you see if this file matches what you are looking for:
...Biomarinpharmaceuticalinc notestoconsolidatedfinancialstatements in thousands of u s dollars except per share amounts or as otherwise disclosed thecompany slevel securities are valued using third party pricing sources which generally use observable market prices interest rates and yield curves at commonly quoted intervals similar assets inputs for the company validates provided by its services understanding models used obtaining values from other analyzing data certain instances confirming those traded active markets due to continued volatility associated with conditions greece reduced trading activity sovereign debt classified million greek government issued bonds level december see note further information regarding financial instruments liabilities estimated a probability based income approach utilizing an appropriate discount rate subsequent changes fair value contingent acquisition consideration payable resulting revision key assumptions will be recorded intangible asset amortizat...